American Oriental Bioengineering Inc
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respir… Read more
Market Cap & Net Worth: American Oriental Bioengineering Inc (AOBI)
American Oriental Bioengineering Inc (PINK:AOBI) has a market capitalization of $36.50 ($36.50) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50885 globally and #15611 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying American Oriental Bioengineering Inc's stock price $0.00 by its total outstanding shares 72991 (72.99K).
American Oriental Bioengineering Inc Market Cap History: 2015 to 2025
American Oriental Bioengineering Inc's market capitalization history from 2015 to 2025. Data shows change from $218.97K to $36.50 (-55.50% CAGR).
American Oriental Bioengineering Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how American Oriental Bioengineering Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AOBI by Market Capitalization
Companies near American Oriental Bioengineering Inc in the global market cap rankings as of March 18, 2026.
Key companies related to American Oriental Bioengineering Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
American Oriental Bioengineering Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, American Oriental Bioengineering Inc's market cap moved from $218.97K to $ 36.50, with a yearly change of -55.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $36.50 | 0.00% |
| 2024 | $36.50 | 0.00% |
| 2023 | $36.50 | +150.00% |
| 2021 | $14.60 | -96.36% |
| 2020 | $401.45 | -99.89% |
| 2019 | $364.95K | +371.70% |
| 2018 | $77.37K | -11.67% |
| 2017 | $87.59K | -77.78% |
| 2016 | $394.15K | +80.00% |
| 2015 | $218.97K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of American Oriental Bioengineering Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.50 USD |
| MoneyControl | $36.50 USD |
| MarketWatch | $36.50 USD |
| marketcap.company | $36.50 USD |
| Reuters | $36.50 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.